- Home
- SLGL vs DLHC Comparison
SLGL vs DLHC Comparison
Compare SLGL & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- DLHC
- Stock Information
- Founded
- SLGL 1997
- DLHC 1969
- Country
- SLGL Israel
- DLHC United States
- Employees
- SLGL N/A
- DLHC N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- DLHC Business Services
- Sector
- SLGL Health Care
- DLHC Consumer Discretionary
- Exchange
- SLGL Nasdaq
- DLHC Nasdaq
- Market Cap
- SLGL 69.1M
- DLHC 80.6M
- IPO Year
- SLGL 2018
- DLHC N/A
- Fundamental
- Price
- SLGL $37.00
- DLHC $6.10
- Analyst Decision
- SLGL Strong Buy
- DLHC
- Analyst Count
- SLGL 1
- DLHC 0
- Target Price
- SLGL $50.00
- DLHC N/A
- AVG Volume (30 Days)
- SLGL 16.8K
- DLHC 10.7K
- Earning Date
- SLGL 11-14-2025
- DLHC 12-03-2025
- Dividend Yield
- SLGL N/A
- DLHC N/A
- EPS Growth
- SLGL N/A
- DLHC 80.25
- EPS
- SLGL N/A
- DLHC 0.31
- Revenue
- SLGL $23,931,000.00
- DLHC $359,723,000.00
- Revenue This Year
- SLGL N/A
- DLHC N/A
- Revenue Next Year
- SLGL $31.17
- DLHC N/A
- P/E Ratio
- SLGL N/A
- DLHC $17.78
- Revenue Growth
- SLGL 264.86
- DLHC N/A
- 52 Week Low
- SLGL $4.01
- DLHC $2.72
- 52 Week High
- SLGL $52.26
- DLHC $9.58
- Technical
- Relative Strength Index (RSI)
- SLGL 53.73
- DLHC 45.69
- Support Level
- SLGL $38.01
- DLHC $5.53
- Resistance Level
- SLGL $42.00
- DLHC $5.97
- Average True Range (ATR)
- SLGL 3.42
- DLHC 0.16
- MACD
- SLGL -0.95
- DLHC -0.00
- Stochastic Oscillator
- SLGL 30.02
- DLHC 10.64
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.